MINAPHARM Pharmaceuticals (EGX: MIPH)

MINAPHARM Pharmaceuticals Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3,196	1,918	1,694	981.94	1,024	764.02
Cash & Short-Term Investments	3,196	1,918	1,694	981.94	1,024	764.02
Cash Growth	-	13.25%	72.47%	-4.06%	33.96%	-6.70%
Accounts Receivable	435.71	492.9	478.14	388.76	331.91	200.14
Other Receivables	37.37	17.56	12.22	5.52	5.67	6.02
Receivables	632.1	714.19	575.06	399.59	358.93	286.39
Inventory	1,276	1,055	838.28	668.51	587.16	481.24
Prepaid Expenses	36.61	10.76	12.41	6.54	5.89	4.34
Other Current Assets	375.75	344.49	524.8	345.77	205.54	163.67
Total Current Assets	5,516	4,042	3,644	2,402	2,181	1,700
Property, Plant & Equipment	5,418	4,251	2,685	1,340	1,004	899.91
Long-Term Investments	5	5	5	5	5	5
Goodwill	340.43	334.51	280.08	220.53	230.21	221.3
Other Intangible Assets	274.61	67.1	56.9	48.2	62.16	65.83
Long-Term Deferred Tax Assets	-	-	-	-	0.81	-
Other Long-Term Assets	274.52	3.22	134.67	89.77	-	-
Total Assets	11,828	8,704	6,806	4,106	3,483	2,892
Accounts Payable	1,065	707.54	677.29	416.64	508.39	304.84
Accrued Expenses	22.36	46.81	39.23	31.53	26.18	22.44
Short-Term Debt	2,762	2,071	1,042	542.29	747.41	791.82
Current Portion of Long-Term Debt	367.28	218.67	225.33	32.93	23.24	21.75
Current Portion of Leases	50.01	27.77	15.1	68.13	-	-
Current Income Taxes Payable	154.71	134.82	233.36	183.69	151.54	84.31
Current Unearned Revenue	15.62	9.81	7.45	5.04	4.44	8.67
Other Current Liabilities	298.26	314.7	261.3	208.89	168.76	162.8
Total Current Liabilities	4,735	3,531	2,501	1,489	1,630	1,397
Long-Term Debt	1,945	1,335	1,036	603.87	187.84	76.79
Long-Term Leases	506.29	153.62	114.83	1.17	-	-
Long-Term Deferred Tax Liabilities	61.26	44.99	56.01	22.69	18.53	26.19
Other Long-Term Liabilities	134.07	121.15	57.52	45.73	53.43	46.72
Total Liabilities	7,382	5,186	3,765	2,163	1,890	1,546
Common Stock	122.93	122.93	122.93	122.93	122.93	122.93
Retained Earnings	2,092	2,147	2,023	1,466	1,047	828.29
Treasury Stock	-69.63	-69.63	-69.63	-	-	-
Comprehensive Income & Other	2,177	1,222	882.83	293.27	367.67	330.09
Total Common Equity	4,323	3,423	2,959	1,882	1,537	1,281
Minority Interest	123.24	94.61	81.82	61.29	56.04	64.04
Shareholders' Equity	4,446	3,517	3,041	1,943	1,593	1,345
Total Liabilities & Equity	11,828	8,704	6,806	4,106	3,483	2,892
Total Debt	5,630	3,806	2,433	1,248	958.49	890.36
Net Cash (Debt)	-2,435	-1,889	-739.64	-266.46	65.01	-126.34
Net Cash Per Share	-220.07	-170.70	-64.46	-21.67	5.29	-10.28
Filing Date Shares Outstanding	11.06	11.06	11.06	12.29	12.29	12.29
Total Common Shares Outstanding	11.06	11.06	11.06	12.29	12.29	12.29
Working Capital	780.88	511.26	1,143	913.2	551.05	303.03
Book Value Per Share	390.74	309.35	267.42	153.07	125.04	104.23
Tangible Book Value	3,708	3,021	2,622	1,613	1,245	994.19
Tangible Book Value Per Share	335.15	273.05	236.96	131.21	101.26	80.87
Land	56.12	39.7	33.23	26.15	27.3	26.24
Buildings	748.41	508.65	411.79	296.6	307.09	290.95
Machinery	2,533	1,777	1,365	977.94	961.26	875.36
Construction In Progress	3,551	2,936	1,666	666.97	357.47	268.1

Source: S&P Capital IQ. Standard template. Financial Sources.